Promega Maxwell® Modular Automated Nucleic Acid Preparation System Allows Customized Workflows for Labs of All Sizes

MADISON, WI USA (November 14, 2017) A modular automated liquid handling and purification system developed by Promega Corporation for its Maxwell® nucleic acid preparation offersgives labs new found flexibility compared to large all-in-one instruments. The configurable system, which launched this week, works with existing Promega Maxwell® RSC instruments with a software upgrade and introduces two new... Read more

New Promega HiBiT Protein Tagging System Easily Combines with CRISPR/Cas9 Knock-in to Simplify Studies of Proteins Under Natural Expression Conditions

MADISON, WI USA (September 26, 2017) Promega Corporation’s new bioluminescent HiBiT Protein Tagging System can be combined with CRISPR/CAS9-mediated gene editing to tag endogenous proteins and simplify their study under natural expression conditions, as demonstrated in “CRISPR-Mediated Tagging of Endogenous Proteins with a Luminescent Peptide,” a recently published paper in the journal ACS Chemical Biology. HiBiT technology, which... Read more

Promega First to Achieve Third-Party Certification of Published ISO 18385 Manufacturing Standard to Minimize Risk of Human DNA Contamination in Forensic Products

MADISON, WI USA (July 11, 2017) Promega Corporation has become the first major forensic manufacturer to achieve third-party certification of the published ISO 18385 standard to minimize the risk of human DNA contamination in products used to collect, store and analyze biological material for forensic purposes. This Forensic DNA Grade certification comes following a recent onsite... Read more

Promega Intends to Seek FDA Approval for Microsatellite Instability Assay to Assist in Strategic Cancer Decisions

MADISON, WI USA (July 6, 2017) Promega Corporation intends to seek US Food and Drug Administration approval and CE-IVD marking for a commercially available Microsatellite Instability (MSI) assay to assist oncologists and pathologists in determining colorectal cancer decisions. MSI status is a measure of mismatch-repair deficiency commonly found in solid tumors. In addition to the colorectal... Read more

Water Quality Testing Advances Ten Times the Current Standards with new Promega AppliTek Collaboration

Madison, WI USA. (March 16, 2017) (March 16, 2017) Rapid and reliable on-line measurement of water quality with sensitivity more than ten times current standards is now available to the water industry. Promega Corporation and AppliTek (Belgium, Europe) are teaming to offer advanced technology for microbial pathogen monitoring of process water and drinking water sources.... Read more

Promega Corporation brings high-performance DNA analysis to the benchtop with new Spectrum Compact CE instrument

Madison, WI USA. (February 14, 2017) (February 14, 2017) Soon scientists will be able to perform efficient DNA analysis right at their bench. Promega Corporation has announced the development of a benchtop capillary electrophoresis (CE) instrument in collaboration with Hitachi High-Technologies Corporation. The Spectrum Compact CE System meets small batch and single sample needs in... Read more